Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.62B |
| 2 |
NVIDIA
NVDA
|
+$2.91B |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$841M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$614M |
| 5 |
Apple
AAPL
|
+$435M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$379M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$341M |
| 3 |
Kenvue
KVUE
|
+$281M |
| 4 |
Linde
LIN
|
+$273M |
| 5 |
DoorDash
DASH
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.55% |
| 2 | Technology | 2.96% |
| 3 | Consumer Discretionary | 1.26% |
| 4 | Financials | 0.68% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDVA
11401
Endovia Health Sciences, Inc.
EDVA
$2.05M
| $64K | ﹤0.01% |
869
-238
| -21% | -$19K |
|
|
MIN
11402
Aberdeen Intermediate Income Fund
MIN
$279M
| $64K | ﹤0.01% |
24,046
+2,288
| +11% | +$6.25K |
|
|
DALN
11403
DELISTED
DallasNews
DALN
| $63.9K | ﹤0.01% |
16,730
-10,056
| -38% | -$41.4K |
|
|
ARIS
11404
Aris Mining
ARIS
$4.39B
| $63.7K | ﹤0.01% |
+17,700
| New | +$54.9K |
|
11405
Marker Therapeutics
MRKR
$24.3M
| $63.7K | ﹤0.01% |
+14,817
| New | +$64.7K |
|
11406
Cue Biopharma
CUE
$205M
| $63.6K | ﹤0.01% |
1,122
+659
| +142% | +$46.5K |
|
11407
CALL
Fusion Fuel Green
HTOO
$14.2M
| $63.5K | ﹤0.01% |
1,074
-60
| -5% | -$2.9K |
|
11408
CALL
Emergent Biosolutions
EBS
$305M
| $63.3K | ﹤0.01% |
+25,000
| New | +$56.4K |
|
11409
CALL
BeyondSpring
BYSI
$26.3M
| $63.2K | ﹤0.01% |
17,700
-117,200
| -87% | -$197K |
|
11410
PUT
Anixa Biosciences
ANIX
$122M
| $63K | ﹤0.01% |
20,200
-13,300
| -40% | -$53K |
|
11411
Vor Biopharma
VOR
$1.39B
| $63K | ﹤0.01% |
1,329
-1,850
| -58% | -$81.2K |
|
|
FRGE
11412
CALL
DELISTED
Forge Global Holdings
FRGE
| $62.9K | ﹤0.01% |
2,173
-154
| -7% | -$4.81K |
|
11413
PUT
ESS Tech
GWH
$14.1M
| $62.9K | ﹤0.01% |
5,820
-1,707
| -23% | -$23.3K |
|
|
ME
11414
CALL
DELISTED
23andMe Holding Co
ME
| $62.8K | ﹤0.01% |
5,920
-2,970
| -33% | -$38.2K |
|
11415
CALL
Gain Therapeutics
GANX
$80.7M
| $62.6K | ﹤0.01% |
+16,600
| New | +$68.8K |
|
11416
PUT
Riskified
RSKD
$808M
| $62.2K | ﹤0.01% |
+11,500
| New | +$54.6K |
|
|
OLO
11417
PUT
DELISTED
Olo Inc
OLO
| $62K | ﹤0.01% |
+11,300
| New | +$61.7K |
|
|
11418
PUT
Cue Biopharma
CUE
$205M
| $62K | ﹤0.01% |
1,093
+236
| +28% | +$16.6K |
|
11419
PUT
PetMed Express
PETS
$40.1M
| $61.3K | ﹤0.01% |
12,800
-2,800
| -18% | -$16.3K |
|
|
TSBX
11420
DELISTED
Turnstone Biologics
TSBX
| $61.2K | ﹤0.01% |
+23,371
| New | +$66.9K |
|
11421
Custom Truck One Source
CTOS
$2.2B
| $60.9K | ﹤0.01% |
10,460
-24,298
| -70% | -$151K |
|
|
WOW
11422
CALL
DELISTED
WideOpenWest
WOW
| $60.8K | ﹤0.01% |
16,800
+2,600
| +18% | +$9.28K |
|
11423
Xeris Biopharma Holdings
XERS
$1.57B
| $60.5K | ﹤0.01% |
27,390
-135,839
| -83% | -$351K |
|
|
GORV
11424
DELISTED
Lazydays
GORV
| $60.5K | ﹤0.01% |
500
-758
| -60% | -$106K |
|
|
ZFOXW
11425
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
| $60.5K | ﹤0.01% |
+672,591
| New | +$34.5K |
|
Similar funds
Jeff Yass's Q1 2024 Portfolio in Review
As of Q1 2024, Jeff Yass held 13,901 positions worth $576B, up 9.6% from $525B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q1 2024 filing shows 1,661 new, 4,870 increased, 5,404 reduced and 1,849 closed positions. Its largest new stake was Grayscale Bitcoin Trust: 19,119,358 shares worth $1.09B. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $379M.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2024 buy was Grayscale Bitcoin Trust: 19,119,358 shares worth $1.09B.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $3.62B increase.
- Jeff Yass's biggest Q1 2024 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $379M.
- Jeff Yass fully exited WisdomTree Japan Hedged Equity Fund in Q1 2024, selling an estimated $34.5M.
- Jeff Yass's ten largest holdings make up 25% of its $576B portfolio in Q1 2024.
- Jeff Yass opened 1,661 new positions and closed 1,849 in Q1 2024.
- Jeff Yass's portfolio value rose 9.6% quarter-over-quarter to $576B.
Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.